Crucell and DSM Announce PER.C6 Licensing Agreement with Mitsubishi Pharma for Protein Production
23. März 2005 02:06 ET | Crucell N.V.
LEIDEN, The Netherlands, March 23, 2005 (PRIMEZONE) -- Dutch biotechnology company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) and allied contract manufacturer DSM Biologics announced today that DSM...